Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2008 1
2013 1
2014 4
2015 1
2019 4
2020 2
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Chin CK, Rodriguez MA, Qing Y, Feng L, Samaniego F, Jain P, Noorani M, Fowler NH, Fayad LE, Westin JR, Neelapu SS, Hagemeister FB, Flowers CR, Nastoupil LJ. Chin CK, et al. Among authors: qing y. Leuk Lymphoma. 2020 Dec;61(12):2985-2989. doi: 10.1080/10428194.2020.1789631. Epub 2020 Jul 6. Leuk Lymphoma. 2020. PMID: 32628087 No abstract available.
Extremity replantation.
Chung-Wei C, Yun-Qing Q, Zhong-Jia Y. Chung-Wei C, et al. Among authors: yun qing q. World J Surg. 1978 Jul;2(4):513-24. doi: 10.1007/BF01563690. World J Surg. 1978. PMID: 716455 No abstract available.
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis.
Manasanch EE, Han G, Mathur R, Qing Y, Zhang Z, Lee H, Weber DM, Amini B, Berkova Z, Eterovic K, Zhang S, Zhang J, Song X, Mao X, Morgan M, Feng L, Baladandayuthapani V, Futreal A, Wang L, Neelapu SS, Orlowski RZ. Manasanch EE, et al. Among authors: qing y. Blood Adv. 2019 Aug 13;3(15):2400-2408. doi: 10.1182/bloodadvances.2019000300. Blood Adv. 2019. PMID: 31405950 Free PMC article.
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial.
Ferrarotto R, Sousa LG, Qing Y, Kaya D, Stephen B, Jain D, Bell D, Pant S, Tsimberidou AM, Janku F, Blumenschein G, Glisson BS, Ahnert JR, Piha-Paul SA, Lee JJ, Wong MK, Lu C, Meric-Bernstam F, Naing A. Ferrarotto R, et al. Among authors: qing y. Adv Ther. 2021 Aug;38(8):4581-4591. doi: 10.1007/s12325-021-01807-6. Epub 2021 Jul 9. Adv Ther. 2021. PMID: 34241781 Clinical Trial.
20 results